Pharmacy benefit managers are increasingly measuring a patient's outcome in the context of adherence.
How can marketers do more with less, or otherwise convince skeptical executives that more resources will lead to long-term change?
Drugmakers and providers alike struggle to find the best tools, words, and technologies that will improve adherence rates among patients with chronic diseases.
Researchers still don't know why Americans who are prescribed a prescription drug to treat a chronic condition or disease so often fail to fill those prescriptions.
The FDA approves first drug to treat tardive dyskinesia; Americans use crowdfund sites to pay for prescriptions; stroke sufferers struggle with adherence
The drugmaker is using Propeller Health's sensor technology to find new ways to improve adherence in clinical studies.
Companies such as Eli Lilly and Medtronic have launched branded apps for their products, but experts say they don't make sense for all medicines.
Where are the discussions about applying proven behavior change models or the principles of adult learning and health literacy?
CeyHello, a newly launched social networking mobile app, tackles medication adherence by connecting patients, caregivers and family members.
Insulet's skin-adhesive technology is being used to improve adherence for patients taking biologics.
Negative news coverage of statins may lead people to stop taking their medication; second patient dies in Zafgen obesity drug trial; Gilead defends pricing
Study shows Merck's Januvia does not increase heart risks; a former Genentech exec launches a behavioral health business; lawmakers want black-box warnings on more opioids
The small screen makes it a user-friendly medication adherence tool.
For all the scientific tools that have fallen into our hands in the past few years, we are still largely falling short in our efforts to influence our audiences' behaviors.
Delivering smarter dynamic communications rather than static timed communications based on self-reported data can help connect patients to information and support that drive brand loyalty and program success.
A small physician survey shows doctors think their patients have higher adherence rates than the norm.
Obama's precision medicine initiative looks set for bipartisan support, Valeant has offered $296 million to buy Dendreon and researchers say Roche's Tamiflu works.
A CVS Health/American Council of the Blind collaboration means some visually impaired patients will soon have more engaging prescription labels.
More cost data for the file the latest data shows that up-front healthcare costs are prompting many patients to delay office visits.
Researchers studying the distribution of brick-and-mortar pharmacies in Chicago link adherence issues with geographic barriers to care.
A mélange of new treatments awaiting approval and a lack of patient support are driving down drug utilization for Gilead's HCV blockbuster, according to a new study.
A study of psoriatic arthritis patients found greater adherence among patients whose initial treatment was a biologic, compared to those who started with a non-biologic treatment.
Researchers at the Brigham and Women's Hospital found that continuity in color and shape have a significant impact on whether patients stick with a prescription regimen.
Patients want to do more with mobile and see doctors less. Two studies outline the types of digital interventions patients are interested in.
Researchers found a correlation between patients feeling involved and how well they stick—if they stick—to their medication regimens.
A survey of patients found greater prescription drug adherence among patients who received a free 30-day sample in addition to a prescription.
A study showed that side-effect fears keep asthmatics from sticking to medication regimens.
A young company is hoping its analytics platform can help doctors and pharma figure out who's going to stop taking their medication, and get them back on track.
Novo's global diabetes study finds that only 29% of polled patients were asked what they thought about prescribed regimens.
A study points out barriers to e-prescribing pharma products and shows how doctors rate various EHRs.